Comparison of hydrochlorothiazide and sustained-release diltiazem for mild-to-moderate systemic hypertension

The American Journal of Cardiology
W H FrishmanH Schnaper


The safety and efficacy of sustained-release diltiazem, 120 to 180 mg twice daily, was compared with those of hydrochlorothiazide, 25 to 50 mg twice daily, in 207 patients with mild-to-moderate hypertension (supine diastolic blood pressure [BP] 95 to 114 mm Hg) using a baseline, placebo, parallel-design study protocol. All patients received placebo for 2 to 4 weeks, followed by either study drug during the double-blind phase, titrated over 8 weeks to achieve a goal of supine diastolic BP reduction of at least 10 mm Hg and/or a diastolic BP of less than 90 mm Hg. Patients not achieving the treatment goal with either drug alone received the other drug in combination. Both drugs produced significant decreases in supine and upright BP throughout the 26-week study. The magnitude of decrease in mean supine diastolic BP was similar for both drugs as monotherapy at week 14 (-11.4 and -12.1 mm Hg, respectively). Hydrochlorothiazide produced significantly greater reductions at week 14 in mean supine systolic BP than sustained-release diltiazem (-19.5 and -12.7 mm Hg, respectively). The difference in mean supine diastolic BP reduction with the 2 drugs diminished when hydrochlorothiazide (50 mg/day) was compared with sustained-release dilt...Continue Reading


May 1, 1978·Japanese Circulation Journal·M KinoshitaT Hoshino
Jul 1, 1986·The American Journal of Cardiology·W H FrishmanE L Michelson
Jul 1, 1983·Hypertension·M D GuazziP Moruzzi
Jun 1, 1984·The American Journal of Cardiology·I K InouyeD Loge
Oct 5, 1984·The American Journal of Medicine·W W Klein
Aug 31, 1984·The American Journal of Medicine·W H FrishmanN Beer
May 1, 1983·The American Journal of Cardiology·R S HornungE B Raftery

❮ Previous
Next ❯


Aug 1, 1993·Journal of Clinical Pharmacology·W H FrishmanA Cretkovic
Mar 1, 1995·Journal of Clinical Pharmacology·M R Weir
Dec 1, 1995·Cardiovascular Drugs and Therapy·T D RuddyA P Boulet
Mar 1, 1990·Cardiovascular Drugs and Therapy·M H Weinberger
Dec 14, 1987·The American Journal of Cardiology·B M Massie
May 17, 1991·The American Journal of Medicine·M R Weir
Jun 1, 1989·Journal of Clinical Pharmacology·P E PoolR R Evans
Sep 17, 2002·Cephalalgia : an International Journal of Headache·S D Silberstein, P J Goadsby
Dec 23, 2003·The Journal of Clinical Hypertension·Marvin Moser
Aug 1, 1989·Journal of the American Geriatrics Society·M BursztynH Gavras
Sep 1, 1988·Drug Intelligence & Clinical Pharmacy·Y W Lam

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.